Passive transfer of experimental autoimmune encephalomyelitis in Wistar rats: Dissociation of clinical symptoms and biochemical alterations

Journal of Neuroscience Research

Volumn 59, Issue 2, 2000, Pages 283-290

  Degano, Alicia L ^b   Roth, German A ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^b NONE

Author keywords

Autoimmunity; Myelin; Myelin basic protein; T lymphocytes

Indexed keywords

MYELIN; MYELIN BASIC PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CELL FUNCTION; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; MALE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT;

2',3'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; ANIMALS; AUTOANTIBODIES; CATTLE; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM; CONCANAVALIN A; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; MALE; MYELIN BASIC PROTEINS; MYELIN SHEATH; RATS; RATS, WISTAR; T-LYMPHOCYTES;

EID: 0034650992     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(20000115)59:2<283::AID-JNR15>3.0.CO;2-S     Document Type: Article

References (28)

1. Bouwer HGA, Hinrichs DJ. 1994. Adoptive transfer of experimental allergic encephalomyelitis. Recipient response to myelin basic proteinreactive lymphocytes. J Neuroimmunol 54:87-98.
2. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
3. De Brito FB, Hanahoe THP. 1983. Susceptibility of two colonies of Wistar rats to inflammation with particular reference to delayed hypersensitivity. Int Arch Allerg Appl Immunol 72:164-169.
4. Degamo AL, Bucher AE, Roth GA. 1998. Suppression of acute experimental allergic encephalomyelitis by intraperitoneal administration of synaptosomal antigens. J Neurosci Res 53:187-194.
5. Gunther E, Odenthal H, Wechsler W. 1978. Association between susceptibility to experimental allergic encephalomyelitis and the major histocompatibility system in congenic rat strains. Clin Exp Immun 32:429-434.
6. Hashim GA. 1985. Neural antigens and the development of autoimmunity. J Immunol 135(Suppl):838-842.
7. Hughes RAC, Stedronska J. 1973. The susceptibility of rat strains to experimental allergic encephalomyelitis. Immunology 24:879-884.
8. Kawai K, Ito K, Imamura K, Hickey WF, Zweman B, Takahashi A. 1993. Enhancing effects of irrelevant lymphocytes on adoptive transferred experimental allergic encephalomyelitis. J Neuroimmunol 42:39-45.
9. Kerlero de Rosbo N, Ben-Nun A. 1999. Experimental autoimmune encephalomyelitis induced by various antigens of the central nervous system: overview and relevance to multiple sclerosis. In: Shoenfeld Y. editor. The decade of autoimmunity. Amsterdam: Elsevier, p 169-177.
10. Lyman WD, Roth GA, Brosnan CF, Bornstein MB, Raine CS. 1988. Quantitation of antigen-specific T cell-induced demyelination in vitro. J Neuroimmunol 17:175-180.
11. Maggio B, Cumar FA. 1975. Experimental allergic encephalomyelitis: dissociation of neurological symptoms from lipid alterations in brain. Nature 253:364-365.
12. Maggio B, Cumar FA, Roth GA, Monferran CG, Fidelio GD. 1983. Neurochemical and model membrane studies in demyelinating diseases. Acta Neuropathol 9(Suppl):71-85.
13. Mor F, Lohse AW, Karin N, Cohen IR. 1990. Clinical modeling of T cell vaccination against autoimmune diseases in rats. Selection of antigen-specific T cells using a mitogen. J Clin Invest 85:1594-1598.
14. Namer IJ, Steibel J, Poulet P, Armspach JP, Mohr M, Mauss Y, Chambron J. 1993. Blood-brain barrier breakdown in MBP-specific T cell induced experimental allergic encephalomyelitis. A quantitative in vivo MRI study. Brain 116:147-159.
15. Namer IJ, Steibel J, Poulet P, Mauss Y, Mohr M, Chambron J. 1994. The role of Mycobacterium tuberculosis in experimental allergic encephalomyelitis. Eur Neurol 34:224-227.
16. Norton WT, Poduslo SE. 1973. Myelination of rat brain: method of myelin isolation. J Neurochem 21:749-757.
17. Paterson PY, Swanborg RH. 1988. Demyelinating diseases of the central and peripheral nervous system. In: Samter M, Talmage DW, Frank MM, Austen KF, Claman HN, editors. Immunological diseases. Boston: Little, Brown and Company, p 1877-1916.
18. Panitch HS, McFarlin DE. 1977. Experimental allergic encephalomyelitis: enhancement of cell-mediated transfer by concanavalin A. J Immunol 119:1134-1137.
19. Richert JR, Driscoll BF, Kies MW, Alvord EC. 1979. Adoptive transfer of experimental allergic encephalomyelitis: incubation of rat spleen cells with specific antigen. J Immunol 122:494-496.
20. Rivero VE, Riera CM, Roth GA. 1999. Humoral response against myelin antigens in two strains of rats with different susceptibility to experimental allergic encephalomyelitis (EAE). Autoimmunity 29: 129-137.
21. Roth GA, Bornstein MB. 1984. Quantitative chemical analysis of demeyelination in cultured mouse spinal cord. Dev Brain Res 15:105-111.
22. Roth GA, Obata K. 1991. Experimental allergic encephalomyelitis: dissociation of immunochemical and clinicopathological responses in two strains of rats. Neurochem Int 19:213-220.
23. Roth GA, Yu RK, Bornstein MB. 1983. Chemical analysis of organotypic cultures of mouse spinal cord in normal, demyelinative, and nondemyelinative conditions. J Neurochem 41:1710-1717.
24. Slavin DA, Bucher AE, Degano AL, Soria NW, Roth GA. 1996. Time course of biochemical and immunohistological alterations during experimental allergic encephalomyelitis. Neurochem Int 29:597-605.
25. Swanborg RH. 1988. Experimental allergic encephalomyelitis. Methods Enzymol 162:418-421.
26. Tsukada Y, Kurihara T. 1992. 2′,3′-cyclic nucleotide 3′-phosphodiesterase: Molecular characterization and possible functional significance. In: Martenson RF, editor. Myelin: biology and chemistry. Boca Raton, FL: CRC Press. p 449-480.
27. Wekerle H. 1993. T-cell autoimmunity in the central nervous system. Intervirology 35:95-100.
28. Wisniewski HM, Bloom BR. 1975. Primary demyelination as a non-specific consequence of a cell-mediated immune reaction. J Exp Med 141:346-359.